Comments
Loading...
Gossamer Bio (GOSS) Forecast
NewsEarningsGossamer Bio (GOSS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestGossamer Bio (NASDAQ:GOSS) Stock Quotes, Forecast and News Summary
Gossamer Bio Stock (NASDAQ: GOSS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Gossamer Bio (GOSS) stock?
You can purchase shares of Gossamer Bio (NASDAQ:GOSS) through any online brokerage.
Who are Gossamer Bio (GOSS) competitors?
Other companies in Gossamer Bio’s space includes: Anika Therapeutics (NASDAQ:ANIK), aTyr Pharma (NASDAQ:ATYR), Monte Rosa Therapeutics (NASDAQ:GLUE), Olema Pharmaceuticals (NASDAQ:OLMA) and Ironwood Pharmaceuticals (NASDAQ:IRWD).
What is the forecast, or price target, for Gossamer Bio (GOSS) stock?
Gossamer Bio has a consensus price target of $7.04.
What is the current price for Gossamer Bio (GOSS)?
The stock price for Gossamer Bio (NASDAQ: GOSS) is $1.235 last updated February 25, 2025 at 12:22 PM EST.
Does Gossamer Bio (GOSS) pay a dividend?
There are no upcoming dividends for Gossamer Bio.
When is Gossamer Bio (NASDAQ:GOSS) reporting earnings?
Gossamer Bio’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
Is Gossamer Bio (GOSS) going to split?
There is no upcoming split for Gossamer Bio.
What sector and industry does Gossamer Bio (GOSS) operate in?
Gossamer Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.